Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2392815Generated: October 27, 2026

ethyl N-(2,3-dichloro-6-nitrobenzyl)glycine hydrochloride → HCID 86753058, compound

https://huagongshe.com/reaction/2392815

Reaction equation

Participants

RoleNameHCIDCharge
Reactantethyl N-(2,3-dichloro-6-nitrobenzyl)glycine hydrochlorideHCID 66640009—
ReactantTin (II) chloride-hydrochlorideHCID 86589141—
ReactantAnagrelideHCID 135409400—
ProductHCID 86753058HCID 86753058—

Reaction Steps

The ethyl-N-(2,3-dichloro-6-nitro benzyl) glycine HCl prepared above was used to make Anagrelide by known reactions. Firstly, the ethyl-N-(2,3-dichloro-6-nitro benzyl) glycine HCl is reacted with SnCl2 /HCl to form ethyl-N-(2,3-dichloro-6-amino benzyl) glycine HCl. This material is then reacted with CNBr in an inert, aprotic organic solvent such as toluene or chlorobenzene. The formed ethyl-N-(5,6-dichloro-3,4-dihydro-2(1 H) iminoguinazoline-3-acetate HCl is isolated and then reacted with a base such as triethanolamine (TEA) to form Anagrelide. This synthesis process is shown in U.S. Pat. No. 4,146,718, supra. The Anagrelide product produced had the characteristic pharmaceutical properties of commercially available Anagrelide made using for example, the present prior art synthesis process as described above.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05801245
Source datasetuspto-grants-1998_09
ORD IDord-538979e87d39453fa35983b3942b1728
Source noteuspto-grants-1998_09